Prostate cancer — all decisions

The Board dismissed the veteran's claims for increased ratings and TDIU due to various conditions, as the issues were remanded under the modernized appeal system.

The Board remands the claims for service connection for diabetes mellitus, prostate cancer, a skin condition, and a bilateral foot condition due to insufficient evidence in the file.

The Board granted an effective date of March 22, 2019, for the awards of service connection for arteriosclerotic heart disease (CAD), prostate cancer, and hypertension.

The Board remands the claim for service connection for prostate cancer to correct a duty to assist error in satisfying the regulatory duty to provide the Veteran with notice of his right to a pre-decisional hearing.

The Board denied service connection for a low back disability, to include lumbar spondylosis; residuals of prostate carcinoma (claimed as prostate cancer); and increased ratings for degenerative changes with meniscal tear of the right knee and sinusitis. The Veteran's combined disability evaluation was also denied.

The Board granted service connection for coronary artery disease, prostate cancer, and bladder cancer due to presumed exposure to herbicide agents during the Veteran's service in the Korean DMZ.

The Board remands the claims for service connection for left shoulder pain, right shoulder pain, low back pain, prostate cancer, erectile dysfunction, and high blood pressure to correct pre-decisional duty to assist errors.

The Board denied higher ratings for prostate cancer, ED, and hypertension but granted a 10 percent initial rating for hypertension. Service connection was denied for lung cancer, bladder cancer, hyperglycemia, and COPD.

The Board granted service connection for neoplasm of the colon, including polyps and reopened a claim for prostate cancer. The claims for incisional hernia repair and psychiatric disability were remanded.

The Board granted an effective date of July 31, 2020, for the award of service connection for anterior trunk scar and an initial 70 percent disability rating for major depressive disorder.

The claims for service connection for diabetes, prostate cancer, and hypertension are remanded for further development regarding potential herbicide exposure outside of Vietnam.

The Board remands the claims for service connection for prostate cancer and bladder condition to allow for readjudication based on new evidence.

The Board granted service connection for diabetes mellitus type II due to Agent Orange exposure and granted a total disability rating based on individual unemployability due to the Veteran's service-connected disabilities, while remanding an increased rating claim for residuals of prostate cancer (voiding dysfunction).

The Board granted a greater 60 percent rating for the Veteran's residuals of prostate cancer status post radical prostatectomy and a total disability rating based on individual unemployability (TDIU).

The Board denied ratings in excess of 60 percent for prostate cancer, 30 percent for PTSD, and noncompensable ratings for hypertension and chronic kidney disease. However, TDIU was granted due to the Veteran's service-connected disabilities.

The Board denied service connection for various disabilities, including lumbar spine degenerative disc disease, right and left lower extremity disabilities, nausea, hypertension, loss of smell, loss of taste, kidney disorder, prostatic hypertrophy, prostate cancer, post cranial nodes, boils on the shoulders, armpits, groin, and neck, gynecomastia, and an ear tumor. The claims were denied as there was no evidence linking these conditions to service or toxic exposure at Camp Lejeune.

The Board granted service connection for coronary artery disease and prostate cancer under the PACT Act but remanded claims for further evidence regarding other bases.

The Board denied service connection for prostate cancer as the evidence did not support a finding that it was related to the Veteran's active service, including any exposure to hazardous chemicals.

The Board denied service connection for prostate cancer as it was not related to any disease, injury, or incident during the Veteran's service.

The Board granted an effective date of August 17, 2022, for the award of service connection for type II diabetes mellitus and residuals of prostate cancer.